Rosetta Inks Agreement with Three Rivers to Offer Access to Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has signed a credentialing agreement with Three Rivers Provider Network, which will offer the firm's Cancer Origin Test to members of the preferred provider organization.

Three Rivers, based in Chula Vista, Calif., provides health benefits to more than 10 million members nationwide. It also has more than 600,000 providers, 5,000 hospitals, and 70,000 ancillary facilities in its network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.